Tianjin Lisheng Pharmaceutical Co.,Ltd.

¥12.93As of Sun 8 Nov 2026, 12:00 UTC
SZSE:002393Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (5.40%)
Div yield 7.73%
ROE 2.74%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) —
PE TTM 32.54
TSR TTM (26.13%)
Mkt cap ¥3.975B
ROIC 4.07%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥15
15.23%
(65.65%)
Hold 5|5|10|4|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.19
0.19
0.19
0.19
16.58%
14.23%
8.71%
1.42%
Revenue¥M
283.3
296.0
304.6
313.7
(5.22%)
(0.61%)
4.98%
8.44%
Peers (US$595.9M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.708
1.467
1.335
EBIT/Intx
2.805
0.106
0.117
Own earn%
17.74
37.04
42.68
Sh yield%
46.58
53.55
49.70
Owners
Insiders/Inst%
2.12
80.54
Short interest%
3.00
SBC / revenue%
3.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
9–19
$1 testx
—
Incr. ROIC%
5